Monthly jab could replace daily steroid pill for people with asthma View Image

A monthly injection could help people with severe asthma come off daily steroid tablets entirely without any impact on symptoms, a trial has found. Tezepelumab – also known as Tezspire and made by AstraZeneca – works by binding to and blocking a protein that drives airway inflammation.

It was given the go-ahead for NHS use by the National Institute for Health and Care Excellence (Nice) in 2023. The injection is recommended as an additional maintenance treatment for patients over 12 when the usual medications have not worked well enough.

Severe asthma can be treated with steroid tablets. However, taking steroids for long periods can have side effects such as mood changes, stomach problems or weight gain

See Full Page